[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:bestrophin-1":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Bestrophin-1",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07185256","Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:46.948970Z","2026-05-05T02:43:26.716969Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05809635","Study of BEST1 Vitelliform Macular Dystrophy",[],"2026-08-26T02:15:28.524219Z","2026-05-13T02:55:06.377944Z"]